Edwards Lifesciences Corporation (BIT:1EW)

Market Cap	36.85B
Revenue (ttm)	5.25B
Net Income (ttm)	4.03B
Shares Out	n/a
EPS (ttm)	6.73
PE Ratio	9.14
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	37
Open	62.01
Previous Close	62.01
Day's Range	62.01 - 62.01
52-Week Range	55.14 - 85.44
Beta	n/a
RSI	8.95
Earnings Date	Apr 23, 2025

About Edwards Lifesciences

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solution...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1958
• Employees: 15,800
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1EW

Financial Performance

In 2024, Edwards Lifesciences's revenue was $5.44 billion, an increase of 8.57% compared to the previous year's $5.01 billion. Earnings were $4.17 billion, an increase of 197.68%.

Financial numbers in USD